Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pfizer gets into in vivo CAR-T through licensing deal with Starna Therapeutics

Pfizer is set to pay $330 million upfront to Starna Therapeutics to take exclusive rights to three pre-IND in vivo CAR-T assets in autoimmune disease outside of Greater China. Plus, the pharma will also get ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Wednesday 18 November →